美国国立癌症研究所的研究人员说,对动物皮肤黑素瘤模型皮内注射卡介苗(BCG)在肿瘤治疗中是一个显著进展。目前开始用BCG作膀胱内输注治疗复发性表浅膀胱肿瘤和原位膀胱癌。美国波士顿大学的泌尿科副教授Babayan说“BCG的效力大于我们使用的任何药物,保护作用似可持续到疗程结束后至少2年”。迄今,Babayan治疗了100多例患者,并公布了其中77例患者的治疗情况——其 Researchers at the National Cancer Institute said intradermal BCG injection in animal cutaneous melanoma models represents a significant advance in cancer therapy. Currently used for intravesical BCG infusion of recurrent superficial bladder cancer and in situ bladder cancer. Babayan, an urology associate at Boston University in the United States, said “BCG is more effective than any of the drugs we use, and the protective effect seems sustainable for at least 2 years after the end of treatment.” To date, Babayan has treated more than 100 patients and published the treatment of 77 of these patients - their